DepoMed Inc
Most Recent
Behind Depomed’s Business Strategy
Depomed (DEPO) has adopted a three-pronged business strategy with three key elements: maintain, build, and grow.
Depomed versus Peers in March 2018: Analyst Ratings
Depomed (DEPO) is a specialty pharmaceutical company with a focus on pain and CNS (central nervous system) conditions.
A Look at Cara Therapeutics’ Intravenous CR845
Intravenous CR845 for pruritus Pruritus is associated with chronic conditions such as chronic kidney disease (or CKD), atopic dermatitis, eczema, cholestatic liver disease, and psoriasis. Based on CR845’s effectiveness on the peripheral nervous system and immune cells, as well as its anti-pruritic potency, Cara Therapeutics (CARA) believes the drug has the potential to treat pruritus […]
How GlaxoSmithKline’s Consumer Healthcare Segment Fared in 1Q17
With improvements in the supply chain and the successful launch of new products, GlaxoSmithKline (GSK) is optimistic about its consumer healthcare segment performance in coming years.
A Look at GlaxoSmithKline’s Consumer Healthcare Business
Following improvements in its supply chain and its successful launch of new products, GlaxoSmithKline is optimistic about its Consumer Healthcare segment.
GSK Optimistic about Future of Its Consumer Healthcare Segment
With improvements in the supply chain and successful launch of new products, GlaxoSmithKline (GSK) is optimistic about its consumer healthcare segment performance.
Horizon Rose and Outperformed IBB’s Mid-Cap Stocks
Horizon Pharma rose 5.4% on November 16, 2015. The stock rose due to the update at the shareholder meeting regarding the Depomed acquisition.
PJP and PBE Are Sectoral Smart Beta Funds
The PowerShares Dynamic Pharmaceuticals Portfolio ETF (PJP) is a smart beta fund that tracks the performance of the Dynamic Pharmaceutical Intellidex Index.